References
- Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 2014;64:83-103.
- Friedman DL, Meadows AT. Late effects of childhood cancer therapy. Pediatr Clin North Am 2002;49:1083-6.
- Wolden SL, Chen L, Kelly KM, Herzog P, Gilchrist GS, Thomson J, et al. Long-term results of CCG 5942: A randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin’s lymphoma-a report from the children’s oncology group. J Clin Oncol 2012;30:3174-80.
- Robison LL, Hudson MM. Survivors of childhood and adolescent cancer: Life-long risks and responsibilities. Nat Rev Cancer 2014;14:61-70.
- Sloan FA, Gelband H. The cancer burden in low-and middle-income countries and how it is measured. In: Cancer Control Opportunities in Low-and Middle-Income Countries 2007. United States: National Academies Press; 2007.
- Cairo MS, Gerrard M, Sposto R, Auperin A, Pinkerton CR, Michon J, et al. Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents. Blood 2007;109:2736-43.
- Gerrard M, Cairo MS, Weston C, Auperin A, Pinkerton R, Lambilliote A, et al. Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin’s lymphoma: Results of the FAB/LMB 96 international study. Br J Haematol 2008;141:840-7.
- Hann I, Vora A, Harrison G, Harrison C, Eden O, Hill F, et al. Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: Results from medical research council United Kingdom acute lymphoblastic leukaemia XI protocol. Br J Haematol 2001;113:103-14.
- Vora A, Goulden N, Wade R, Mitchell C, Hancock J, Hough R, et al. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): A randomised controlled trial. Lancet Oncol 2013;14:199-209.
- Friedman DL, Himelstein B, Shields CL, Shields JA, Needle M, Miller D, et al. Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 2000;18:12-7.
- Mann JR, Raafat F, Robinson K, Imeson J, Gornall P, Phillips M, et al. UKCCSG’s germ cell tumour (GCT) studies: Improving outcome for children with malignant extracranial non-gonadal tumourscarboplatin, etoposide, and bleomycin are effective and less toxic than previous regimens. United Kingdom children’s cancer study group. Med Pediatr Oncol 1998;30:217-27.
- Graf N, Tournade MF, de Kraker J. The role of preoperative chemotherapy in the management of Wilms’ tumor: The SIOP studies. International society of pediatric oncology. Urol Clin North Am 2000;27:443-54.
- Green DM. The treatment of stages I-IV favorable histology Wilms’ tumor. J Clin Oncol 2004;22:1366-72.
- Körholz D, Hamish W. Radiotherapy Manual; 2020. Available from: https://www.skion.nl/workspace/uploads/euronet-phl-c1_workingcopy_inkl_ amendm06_mw_2012-11-14_0.pdf. [Last accessed on 2020 May 01].
- Hann I, Vora A, Richards S, Hill F, Gibson B, Lilleyman J, et al. Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: Results from MRC UKALL XI and MRC ALL97 randomised trials. UK medical research council’s working party on childhood leukaemia. Leukemia 2000;14:356-63.
- Coppes MJ, Wolff JE, Ritchey ML. Wilms tumour: Diagnosis and treatment. Paediatr Drugs 1999;1:251-62.
- World Health Organization. Prevention of Blindness and Deafness: Grades of Hearing Impairment. Geneva: World Health Organization; 2011. Available from: http://www.who.int/pbd/deafness/hearing_impairment_grades/en/index.html. [Last accessed on 2011 July 01].
- MacIntyre N, Crapo R, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005;26:720-35.
- Kapelari K, Kirchlechner C, Högler W, Schweitzer K, Virgolini I, Moncayo R. Pediatric reference intervals for thyroid hormone levels from birth to adulthood: A retrospective study. BMC Endocr Disord 2008;8:15.
- Langer T, Grabow D, Steinmann D, Wörmann B, Calaminus G. Late effects and long-term follow-up after cancer in childhood. Oncol Res Treat 2017;40:746-50.
- Livinalli A, Silva MT, Lopes LC. Late adverse effects related to treatment in a cohort of survivors of childhood and adolescent cancer. Medicine (Baltimore) 2019;98:e14921.
- Travis LB, Hill DA, Dores GM, Gospodarowicz M, van Leeuwen FE, Holowaty E, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA 2003;290:465-75.
- Temming P, Arendt M, Viehmann A, Eisele L, Le Guin CH, Schündeln MM, et al. Incidence of second cancers after radiotherapy and systemic chemotherapy in heritable retinoblastoma survivors: A report from the German reference center. Pediatr Blood Cancer 2017;64:71-80.
- Chojnacka M, Pędziwiatr K, Skowrońska-Gardas A, Perek-Polnik M, Perek D, Olasek P. Second brain tumors following central nervous system radiotherapy in childhood. Br J Radiol 2014;87:20140211.
- Friedman DL, Whitton J, Leisenring W, Mertens AC, Hammond S, Stovall M, et al. Subsequent neoplasms in 5-year survivors of childhood cancer: The childhood cancer survivor study. J Natl Cancer Inst 2010;102:1083-95.
- Teepen JC, Kremer L, Ronckers CM, Van Leeuwen FE, Hauptmann M, Broeder VD, et al. Long-term risk of subsequent malignant neoplasms after treatment of childhood cancer in the DCOG LATER study cohort: Role of chemotherapy. J Clin Oncol 2017;35:2288-98.
- Maule M, Scélo G, Pastore G, Brennan P, Hemminki K, Tracey E, et al. Risk of second malignant neoplasms after childhood leukemia and lymphoma: An international study. J Natl Cancer Inst 2007;99:790-800.
- Wasilewski-Masker K, Seidel KD, Leisenring W, Mertens AC, Shnorhavorian M, Ritenour CW, et al. Male infertility in long-term survivors of pediatric cancer: A report from the childhood cancer survivor study. J Cancer Surviv 2014;8:437-47.
- van Casteren NJ, van der Linden GH, Hakvoort-Cammel FG, Hählen K, Dohle GR, van den Heuvel-Eibrink MM. Effect of childhood cancer treatment on fertility markers in adult male long-term survivors. Pediatr Blood Cancer 2009;52:108-12.
- Da Cunha MF, Meistrich ML, Fuller LM, Cundiff JH, Hagemeister FB, Velasquez WS, et al. Recovery of spermatogenesis after treatment for Hodgkin’s disease: Limiting dose of MOPP chemotherapy. J Clin Oncol 1984;2:571-7.
- Buchanan JD, Fairley KF, Barrie JU. Return of spermatogenesis after stopping cyclophosphamide therapy. Lancet 1975;306:156-7.
- Ramjaun A, AlDuhaiby E, Ahmed S, Wang L, Yu E, Nathan PC, et al. Echocardiographic detection of cardiac dysfunction in childhood cancer survivors: How long is screening required? Pediatr Blood Cancer 2015;62:2197-203.
- Mulrooney DA, Armstrong GT, Huang S, Ness KK, Ehrhardt MJ, Joshi VM, et al. Cardiac outcomes in adult survivors of childhood cancer exposed to cardiotoxic therapy: A cross-sectional study from the St. Jude lifetime cohort. Ann Intern Med 2016;164:93-101.
- Hu H, Zhang W, Huang D, Yang Q, Li J, Gao Y. Cardiotoxicity of anthracycline (ANT) treatment in children with malignant tumors. Pediatr Hematol Oncol 2018;35:111-20.
- Kasteler R, Weiss A, Schindler M, Sommer G, Latzin P, von der Weid NX, et al. Long-term pulmonary disease among Swiss childhood cancer survivors. Pediatr Blood Cancer 2018;65:e26749.
- Huang TT, Hudson MM, Stokes DC, Krasin MJ, Spunt SL, Ness KK. Pulmonary outcomes in survivors of childhood cancer: A systematic review. Chest 2011;140:881-901.
- Sklar C, Whitton J, Mertens A, Stovall M, Green D, Marina N, et al. Abnormalities of the thyroid in survivors of Hodgkin’s disease: Data from the childhood cancer survivor study. J Clin Endocrinol Metab 2000;85:3227-32.
- Vogelius IR, Bentzen SM, Maraldo MV, Petersen PM, Specht L. Risk factors for radiation-induced hypothyroidism: A literature-based meta-analysis. Cancer 2011;117:5250-60.
- Travis LB, Fossa SD, Sesso HD, Frisina RD, Herrmann DN, Beard CJ, et al. Chemotherapy-induced peripheral neurotoxicity and ototoxicity: New paradigms for translational genomics. J Natl Cancer Inst 2014;106:dju044.
- Shimoda S, Horsman J, Furlong W, Barr R, de Camargo B. Disability and health-related quality of life in long-term survivors of cancer in childhood in Brazil. J Pediatr Hematol Oncol 2008;30:563-70.
- Bava L, Johns A, Kayser K, Freyer DR. Cognitive outcomes among Latino survivors of childhood acute lymphoblastic leukemia and lymphoma: A cross-sectional cohort study using culturally competent, performance-based assessment. Pediatr Blood Cancer 2018;65:e26844.
- Clemens E, van der Kooi AL, Broer L, van Dulmenden Broeder E, Visscher H, Kremer L, et al. The influence of genetic variation on late toxicities in childhood cancer survivors: A review. Crit Rev Oncol Hematol 2018;126:154-67.
- Clemens E, Meijer AJ, Broer L, Langer T, van der Kooi AL, Uitterlinden AG, et al. Genetic determinants of ototoxicity during and after childhood cancer treatment: Protocol for the pancarelife study. JMIR Res Protoc 2019;8:e11868.
- Van der Kooi AL, Clemens E, Broer L, Zolk O, Byrne J, Campbell H, et al. Genetic variation in gonadal impairment in female survivors of childhood cancer: A pan care life study protocol. BMC Cancer 2018;18:930.
- Zheng DJ, Sint K, Mitchell HR, Kadan-Lottick NS. Patterns and predictors of survivorship clinic attendance in a population-based sample of pediatric and young adult childhood cancer survivors. J Cancer Surviv 2016;10:505-13.
- Klosky JL, Cash DK, Buscemi J, Lensing S, Garces-Webb DM, Zhao W, et al. Factors influencing long-term follow-up clinic attendance among survivors of childhood cancer. J Cancer Surviv 2008;2:225-32.